JP2023505221A5 - - Google Patents
Info
- Publication number
- JP2023505221A5 JP2023505221A5 JP2022533441A JP2022533441A JP2023505221A5 JP 2023505221 A5 JP2023505221 A5 JP 2023505221A5 JP 2022533441 A JP2022533441 A JP 2022533441A JP 2022533441 A JP2022533441 A JP 2022533441A JP 2023505221 A5 JP2023505221 A5 JP 2023505221A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- compound
- alkyl
- pharmaceutical composition
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962943728P | 2019-12-04 | 2019-12-04 | |
| US62/943,728 | 2019-12-04 | ||
| PCT/US2020/063137 WO2021113528A1 (en) | 2019-12-04 | 2020-12-03 | Modulators of programmed death-ligand-1 and/or programmed death-ligand-2 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023505221A JP2023505221A (ja) | 2023-02-08 |
| JP2023505221A5 true JP2023505221A5 (https=) | 2023-11-29 |
Family
ID=76222302
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022533441A Pending JP2023505221A (ja) | 2019-12-04 | 2020-12-03 | プログラム死リガンド１および／またはプログラム死リガンド２の調節物質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12098216B2 (https=) |
| EP (1) | EP4069270A4 (https=) |
| JP (1) | JP2023505221A (https=) |
| AU (1) | AU2020396100A1 (https=) |
| CA (1) | CA3159698A1 (https=) |
| WO (1) | WO2021113528A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1144373B1 (en) | 1999-01-13 | 2005-10-19 | Genentech, Inc. | Serine protease inhibitors |
| GB0514071D0 (en) * | 2005-07-07 | 2005-08-17 | Zealand Pharma As | N- or C- terminally modified small peptides |
| EP3092244B1 (en) | 2014-01-10 | 2019-08-14 | Cornell University | Dipeptides as inhibitors of human immunoproteasomes |
| WO2019084455A1 (en) | 2017-10-26 | 2019-05-02 | Southern Research Institute | DIPEPTIDE ANALOGS AS TGF-BETA INHIBITORS |
-
2020
- 2020-12-03 CA CA3159698A patent/CA3159698A1/en active Pending
- 2020-12-03 US US17/778,823 patent/US12098216B2/en active Active
- 2020-12-03 EP EP20896268.8A patent/EP4069270A4/en not_active Withdrawn
- 2020-12-03 AU AU2020396100A patent/AU2020396100A1/en not_active Abandoned
- 2020-12-03 WO PCT/US2020/063137 patent/WO2021113528A1/en not_active Ceased
- 2020-12-03 JP JP2022533441A patent/JP2023505221A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021522197A5 (https=) | ||
| WO2023183585A1 (en) | Kras inhibitors | |
| EP2879677B1 (en) | Substituted pyrazolone compounds and methods of use | |
| JP6382831B2 (ja) | アポトーシス阻害タンパク質（ｉａｐ）のアンタゴニスト | |
| CN102497862B (zh) | 使用ck2调节剂的组合治疗 | |
| HRP20100563T1 (hr) | Derivati dihidropirazolopirimidinona | |
| JP2009514881A5 (https=) | ||
| JP2016502544A5 (https=) | ||
| JP2017521420A5 (https=) | ||
| JP2006508981A5 (https=) | ||
| JP2010533206A5 (https=) | ||
| JP2008528469A5 (https=) | ||
| KR20170090408A (ko) | 벤조-헤테로시클릭 화합물 및 이의 적용 | |
| HRP20100561T1 (hr) | Inhibitori interakcije između mdm2 i p53 | |
| JP2023526283A5 (https=) | ||
| JP2011515397A5 (https=) | ||
| JP2019501195A5 (ja) | 腫瘍を処置するための抗ｅｇｆｒ組み合わせ | |
| RU2016118753A (ru) | Производные пиридилкетона, способ их получения и их фармацевтическое применение | |
| WO2024217502A1 (en) | Methionine adenosyltransferase 2a (mat2a) inhibitor combinations and uses thereof | |
| JP2022537358A5 (https=) | ||
| JP2012518598A5 (https=) | ||
| WO2011028135A1 (en) | Kinase inhibitors, prodrug forms thereof and their use in therapy | |
| JP2023524912A5 (https=) | ||
| JP2019533652A5 (https=) | ||
| AU2002259309B2 (en) | Antineoplastic combinations |